Litcius/Paper detail

Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer

Tie Zhou, Weidong Xu, Wei Zhang, Ye Sun, Ye Sun, Honghua Yan, Xu Gao, Fubo Wang, Qianxiang Zhou, Jianguo Hou, Shancheng Ren, Qing Yang, Bo Yang, Chuanliang Xu, Qingqing Zhou, Meiyu Wang, Chunyun Chen, Yinghao Sun, Yinghao Sun

2020European Journal of Cancer35 citationsDOI

Topics & Concepts

Prostate cancerMedicineAndrogen receptorAntagonistCastrationOncologyInternal medicineAndrogenClinical trialTestosterone (patch)CancerUrologyEndocrinologyReceptorHormoneProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer, Lipids, and Metabolism
Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer | Litcius